Background The use of molecular methods to diagnose Clostridium difficile infection (CDI) has improved diagnostic yield compared to conventional methods. However, PCR testing can detect colonization and has introduced several practical challenges pertaining to need for treatment and isolation of cases. Methods For all new cases detected by real-time PCR, concurrent cytotoxin assay was performed and genetic characterization with MLVA (multi-locus variable number tandem repeat analysis) was done to determine relatedness. We used PCR cycle threshold (Ct) of detection as surrogate marker for bacterial burden in stool. Results Overall, 54 cases of CDI were detected during the study period. 42 were concurrently tested by CYT and characterized by MLVA .MLVA analysis revealed marked genetic diversity with no ongoing outbreaks; four cases were due to NAP1 strain. CYT ?/PCR + cases had a higher median Ct value of detection compared to CYT+/PCR + cases (28.2 vs 22.5; p = 0.01). Among 25 strains that were genetically related, 9/11 isolates in this dominant cluster were positive by CYT compared to 4/14 in non-dominant clusters (p = 0.02). Conclusion CYT?/PCR+ cases contribute to hospital based transmission. However, the risk of transmission of C. difficile from CYT +/PCR+ cases may be higher than those that are CYT?/PCR+.
References
[1]
Kaltsas A, Simon M, Unruh LH, Son C, Wroblewski D, et al. (2012) Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results. J Clin Microbiol 50: 1303–1307. doi: 10.1128/jcm.05711-11
[2]
Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, et al. (2013) Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 56: 67–73. doi: 10.1093/cid/cis840
[3]
Zahariadis G, Connon JJ, Fong IW (2002) Fulminant Clostridium difficile colitis without diarrhea: lack of emphasis in diagnostic guidelines. Am J Gastroenterol 97: 2929–2930.
[4]
Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, et al. (2012) Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 9: e1001172. doi: 10.1371/journal.pmed.1001172
[5]
Babady NE, Stiles J, Ruggiero P, Khosa P, Huang D, et al. (2010) Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 48: 4519–4524. doi: 10.1128/jcm.01648-10
[6]
Hayden Wa Quantitative Molecular Methods, In Molecular Microbiology.
[7]
Marsh JW, O'Leary MM, Shutt KA, Sambol SP, Johnson S, et al. (2010) Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis. J Clin Microbiol 48: 412–418. doi: 10.1128/jcm.01315-09
[8]
Eyre DW, Fawley WN, Best EL, Griffiths D, Stoesser NE, et al. (2013) Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol 51: 4141–4149. doi: 10.1128/jcm.01095-13
[9]
Marsh JW, O'Leary MM, Shutt KA, Pasculle AW, Johnson S, et al. (2006) Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol 44: 2558–2566. doi: 10.1128/jcm.02364-05
[10]
Kamboj M, Son C, Cantu S, Chemaly RF, Dickman J, et al. (2012) Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report. Infect Control Hosp Epidemiol 33: 1162–1165. doi: 10.1086/668023
[11]
Tai E, Richardson LC, Townsend J, Howard E, McDonald LC (2011) Clostridium difficile infection among children with cancer. Pediatr Infect Dis J 30: 610–612. doi: 10.1097/inf.0b013e31820970d1
[12]
Brettle RP, Wallace E (1982) Clostridium difficile from stools of normal children. Lancet 1: 1193. doi: 10.1016/s0140-6736(82)92266-8
[13]
Holst E, Helin I, Mardh PA (1981) Recovery of Clostridium difficile from children. Scand J Infect Dis 13: 41–45.
[14]
Rousseau C, Poilane I, De Pontual L, Maherault AC, Le Monnier A, et al. (2012) Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 55: 1209–1215. doi: 10.1093/cid/cis637
[15]
Stark PL, Lee A, Parsonage BD (1982) Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun 35: 895–899.
[16]
Viscidi R, Willey S, Bartlett JG (1981) Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81: 5–9. doi: 10.1016/s0022-3468(82)80382-5
[17]
Kim J, Shaklee JF, Smathers S, Prasad P, Asti L, et al. (2012) Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J 31: 134–138. doi: 10.1097/inf.0b013e3182352e2c
[18]
Rousseau C, Lemee L, Le Monnier A, Poilane I, Pons JL, et al. (2011) Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol 60: 1112–1118. doi: 10.1099/jmm.0.029736-0
[19]
Toltzis P, Kim J, Dul M, Zoltanski J, Smathers S, et al. (2009) Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. J Pediatr 154: 607–608. doi: 10.1016/j.jpeds.2008.10.016
Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, et al. (2008) Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001–2006. Pediatrics 122: 1266–1270. doi: 10.1542/peds.2008-0469
[22]
Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, et al. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171: 466–472. doi: 10.1503/cmaj.1041104
[23]
Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, et al. (2013) Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 57: 1094–1102. doi: 10.1093/cid/cit475
[24]
Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, et al. (2008) Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol 46: 431–437. doi: 10.1128/jcm.01484-07